Chengye Medical Announces Shareholder Dividend Distribution Resolved by Its Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.
AI Summary (NQ-processed)
Fu Kang Active Pharmaceutical Co., Ltd., a key subsidiary of Chengye Medical, has announced the distribution of cash dividends amounting to NT$77,475,270, as resolved by its shareholders' meeting.
AI Analysis
Frequently Asked Questions
Q: When will the dividend be paid out?
A: The payout date is not specified, but it is typically made within 1-2 months after the shareholders' meeting.
Q: What is Fu Kang Active Pharmaceutical's main business?
A: It primarily engages in the development and distribution of pharmaceutical and health products.
Q: Why is this considered material information?
A: Significant financial distributions impact investor decisions and are therefore classified as material disclosures.